Resumption of injecting drug use following release from prison in Australia

R. J. Winter, J. T. Young, M. Stoové, P. A. Agius, M. E. Hellard, S. A. Kinner

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Introduction Ex-prisoners with a history of injecting drug use (IDU) experience disproportionate drug-related harm. Rapid resumption of substance use following prison release is common and evidenced in high rates of overdose mortality. However, few studies have documented the rate of IDU resumption following prison release or identified risk factors for relapse. Methods Structured interviews were conducted with 533 adults with a history of IDU in Queensland, Australia prior to release from prison and approximately 1, 3 and 6 months post-release. Incidence of self-reported IDU resumption was calculated overall and for each follow-up interval. Risk factors associated with time to resumption of IDU were estimated using discrete-time survival analysis. Results IDU resumption was reported by 41% of participants during a median of 98 days of follow-up (IQR = 94–121), an overall crude incidence of 1.06 per person-year. The highest rate was observed in the first month (23%; crude incidence 2.24 per person-year). In adjusted discrete-time survival analyses, being unemployed at the previous interview (AHR = 1.59; 95%CI:1.10–2.30), shorter incarceration (≤90 days vs. >365 days; AHR = 2.20; 95%CI:1.33–3.65), and IDU during the index incarceration (AHR = 2.80; 95%CI:1.92–4.09) were significantly associated with time to IDU resumption; parole was protective (AHR = 0.66; 95%CI:0.47–0.92). Conclusions Evidence-based efforts to prevent IDU in prison and IDU resumption after release are important for both prisoner and public health. Enhancing opportunities for employment and capitalising on the short-term benefits of parole for ex-prisoners may delay resumption of IDU after release from prison. These strategies should complement rather than replace harm reduction efforts for this high-risk population.

Original languageEnglish
Pages (from-to)104-111
Number of pages8
JournalDrug and Alcohol Dependence
Volume168
DOIs
Publication statusPublished - 1 Nov 2016

Keywords

  • Drug users
  • Follow-up studies
  • Incidence
  • Prisoners
  • Survival analysis

Cite this

@article{b94832c064e3406b83e493956cadad16,
title = "Resumption of injecting drug use following release from prison in Australia",
abstract = "Introduction Ex-prisoners with a history of injecting drug use (IDU) experience disproportionate drug-related harm. Rapid resumption of substance use following prison release is common and evidenced in high rates of overdose mortality. However, few studies have documented the rate of IDU resumption following prison release or identified risk factors for relapse. Methods Structured interviews were conducted with 533 adults with a history of IDU in Queensland, Australia prior to release from prison and approximately 1, 3 and 6 months post-release. Incidence of self-reported IDU resumption was calculated overall and for each follow-up interval. Risk factors associated with time to resumption of IDU were estimated using discrete-time survival analysis. Results IDU resumption was reported by 41{\%} of participants during a median of 98 days of follow-up (IQR = 94–121), an overall crude incidence of 1.06 per person-year. The highest rate was observed in the first month (23{\%}; crude incidence 2.24 per person-year). In adjusted discrete-time survival analyses, being unemployed at the previous interview (AHR = 1.59; 95{\%}CI:1.10–2.30), shorter incarceration (≤90 days vs. >365 days; AHR = 2.20; 95{\%}CI:1.33–3.65), and IDU during the index incarceration (AHR = 2.80; 95{\%}CI:1.92–4.09) were significantly associated with time to IDU resumption; parole was protective (AHR = 0.66; 95{\%}CI:0.47–0.92). Conclusions Evidence-based efforts to prevent IDU in prison and IDU resumption after release are important for both prisoner and public health. Enhancing opportunities for employment and capitalising on the short-term benefits of parole for ex-prisoners may delay resumption of IDU after release from prison. These strategies should complement rather than replace harm reduction efforts for this high-risk population.",
keywords = "Drug users, Follow-up studies, Incidence, Prisoners, Survival analysis",
author = "Winter, {R. J.} and Young, {J. T.} and M. Stoov{\'e} and Agius, {P. A.} and Hellard, {M. E.} and Kinner, {S. A.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.drugalcdep.2016.08.640",
language = "English",
volume = "168",
pages = "104--111",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier",

}

Resumption of injecting drug use following release from prison in Australia. / Winter, R. J.; Young, J. T.; Stoové, M.; Agius, P. A.; Hellard, M. E.; Kinner, S. A.

In: Drug and Alcohol Dependence, Vol. 168, 01.11.2016, p. 104-111.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Resumption of injecting drug use following release from prison in Australia

AU - Winter, R. J.

AU - Young, J. T.

AU - Stoové, M.

AU - Agius, P. A.

AU - Hellard, M. E.

AU - Kinner, S. A.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Introduction Ex-prisoners with a history of injecting drug use (IDU) experience disproportionate drug-related harm. Rapid resumption of substance use following prison release is common and evidenced in high rates of overdose mortality. However, few studies have documented the rate of IDU resumption following prison release or identified risk factors for relapse. Methods Structured interviews were conducted with 533 adults with a history of IDU in Queensland, Australia prior to release from prison and approximately 1, 3 and 6 months post-release. Incidence of self-reported IDU resumption was calculated overall and for each follow-up interval. Risk factors associated with time to resumption of IDU were estimated using discrete-time survival analysis. Results IDU resumption was reported by 41% of participants during a median of 98 days of follow-up (IQR = 94–121), an overall crude incidence of 1.06 per person-year. The highest rate was observed in the first month (23%; crude incidence 2.24 per person-year). In adjusted discrete-time survival analyses, being unemployed at the previous interview (AHR = 1.59; 95%CI:1.10–2.30), shorter incarceration (≤90 days vs. >365 days; AHR = 2.20; 95%CI:1.33–3.65), and IDU during the index incarceration (AHR = 2.80; 95%CI:1.92–4.09) were significantly associated with time to IDU resumption; parole was protective (AHR = 0.66; 95%CI:0.47–0.92). Conclusions Evidence-based efforts to prevent IDU in prison and IDU resumption after release are important for both prisoner and public health. Enhancing opportunities for employment and capitalising on the short-term benefits of parole for ex-prisoners may delay resumption of IDU after release from prison. These strategies should complement rather than replace harm reduction efforts for this high-risk population.

AB - Introduction Ex-prisoners with a history of injecting drug use (IDU) experience disproportionate drug-related harm. Rapid resumption of substance use following prison release is common and evidenced in high rates of overdose mortality. However, few studies have documented the rate of IDU resumption following prison release or identified risk factors for relapse. Methods Structured interviews were conducted with 533 adults with a history of IDU in Queensland, Australia prior to release from prison and approximately 1, 3 and 6 months post-release. Incidence of self-reported IDU resumption was calculated overall and for each follow-up interval. Risk factors associated with time to resumption of IDU were estimated using discrete-time survival analysis. Results IDU resumption was reported by 41% of participants during a median of 98 days of follow-up (IQR = 94–121), an overall crude incidence of 1.06 per person-year. The highest rate was observed in the first month (23%; crude incidence 2.24 per person-year). In adjusted discrete-time survival analyses, being unemployed at the previous interview (AHR = 1.59; 95%CI:1.10–2.30), shorter incarceration (≤90 days vs. >365 days; AHR = 2.20; 95%CI:1.33–3.65), and IDU during the index incarceration (AHR = 2.80; 95%CI:1.92–4.09) were significantly associated with time to IDU resumption; parole was protective (AHR = 0.66; 95%CI:0.47–0.92). Conclusions Evidence-based efforts to prevent IDU in prison and IDU resumption after release are important for both prisoner and public health. Enhancing opportunities for employment and capitalising on the short-term benefits of parole for ex-prisoners may delay resumption of IDU after release from prison. These strategies should complement rather than replace harm reduction efforts for this high-risk population.

KW - Drug users

KW - Follow-up studies

KW - Incidence

KW - Prisoners

KW - Survival analysis

UR - http://www.scopus.com/inward/record.url?scp=84994291740&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2016.08.640

DO - 10.1016/j.drugalcdep.2016.08.640

M3 - Article

VL - 168

SP - 104

EP - 111

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

ER -